Publications by authors named "K Saverno"

Claim this Profile
I
Identification and Confirmation of Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 Rearrangement and Characterization of Treatment Patterns and Outcomes in a Real-World Setting: A US Retrospective Chart Review.
Shreekant Parasuraman, Kimberly Saverno, Kristin M Zimmerman Savill, Philomena Colucci

Acta Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US.
Kim Saverno, Kristin M Zimmerman Savill, Cherrishe Brown-Bickerstaff, Angele Kotomale, Michael Rodriguez

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma.
Narendranath Epperla, Loretta J Nastoupil, Bruce Feinberg, John Galvin, Prathamesh Pathak, Kim Saverno

Biomark Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.
Emily Nash Smyth, Julie Beyrer, Kimberly R Saverno, Elizabeth Hadden, Hamed Abedtash

Drugs Real World Outcomes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer.
Kristin M Sheffield, Jessica R Peachey, Michael Method, Brenda R Grimes, Jacqueline Brown, Kim Saverno

Future Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis